First Hospital of Jilin University
Changchun, Jilin, 130000, China
Location status: Recruiting
NCT Number: NCT05845905
The purpose of this study is to learn about effects of remote ischemic conditioning on blood pressure in older patients with essential hypertension.
Interested in participating?
Request Info65 year–85 year
All sexes
Interventional
Not applicable
Changchun, Jilin, 130000, China
Location status: Recruiting
Current studies have shown that remote ischemic conditioning can improve vascular endothelial function and inhibit sympathetic nervous system activity. Thus it may provide some organ protection as well as anti-hypertensive effects. The purpose of this study is to learn about effects of remote ischemic conditioning on blood pressure in older patients with essential hypertension.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Remote ischemic conditioning (RIC) is induced by 4 cycles of 5 min of upper limb ischemia followed by 5 min reperfusion. Limb ischemia was induced by the inflation of an automated cuff to the pressure rising by 20 mmHg from baseline systolic pressure. RIC will be conducted twice daily for 7 days.
Sham-RIC is performed in the same way as the treatment group except that the blood pressure cuff is inflated to 60 mmHg, which produces mild pressure sensations but has no blocking impact on blood flow.
Time frame: 0-7 days
Difference in mean value of systolic blood pressure during RIC/sham-RIC between two groups.
Time frame: 0-7 days
Difference in mean value of diastolic blood pressure during RIC/sham-RIC between two groups.
Contact information is provided by the study sponsor or research team.
Yi Yang
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03945305
Cardiovascular Diseases, Essential Hypertension
Changchun, Jilin, China
View Trial DetailsNCT06778239
Cardiovascular Diseases, Essential Hypertension
Bethesda, Maryland, United States
View Trial DetailsNCT07282145
Cardiovascular Diseases, Essential Hypertension
Cheongju-si, North Chungcheong, South Korea
View Trial DetailsNCT06643819
Cardiovascular Diseases, Essential Hypertension
Wŏnju, South Korea
View Trial Details